2268 — WuXi XDC Cayman Share News
0.000.00%
Last trade - 00:00- HK$93.92bn
- HK$88.16bn
- CNY5.94bn
HK-listed WuXi XDC hits 10-month peak on solid first-half results
Chinese drugmaker Wuxi XDC's first-half revenue rises on project expansion, acquisition
Brief: WuXi XDC Cayman Posts H1 Revenue Of RMB3,701.4 Million
WuXi XDC climbs on share purchases under company scheme
Brief: Wuxi Xdc Cayman's Trustee Purchases 5.7 Million Shares For HK$326.5 Million
Brief: Wuxi XDC Cayman To Use Up To $100 Mln For Open Market Share Purchase For Share Schemes
Brief: Wuxi Xdc Cayman Inc Posts FY Adjusted Net Profit Attributable RMB1.56 Billion
Brief: Wuxi XDC Enters Strategic Collaboration With Earendil Labs
Brief: Wuxi XDC Cayman Says FY Revenue Expected To Increase By More Than 45%
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
WuXi XDC stock peaks on share sales for service expansion
Brief: Wuxi XDC Cayman Announces Placing Of Up To 22.3 Million Shares
Brief: Wuxi Xdc Cayman To Issue 24.1 Million Shares
Brief: Wuxi Xdc Cayman Says Capital Payment Is Expected To Be RMB1,560Mn In 2025
Brief: Wuxi Xdc Cayman Posts HY Net Profit Attributable RMB745.7 Million
China's WuXi XDC jumps to 20-month high on robust earnings forecast
Brief: Wuxi XDC Cayman Expects Over 67% Increase In Adjusted Net Profit In HY
Brief: WuXi XDC Cayman Posts FY Profit Attributable Of RMB1.07 Bln
Brief: Morgan Stanley's Long Position In Wuxi Xdc Cayman Decreases To 1.97% On Jan 15 - HKEX